Antibiotic use is associated with SJ syndrome and toxic epidermal necrosis, with sulfonamides being the most common culprits.

Published Date: 17 Feb 2023

Antibiotic use linked to SJ syndrome and toxic epidermal necrosis, sulfonamides are worst culprits in new study...

Read Full News

Latest News

Can Bimekizumab Match IL-23 Inhibitors in Psoriasis?

A retrospective study finds that bimekizumab yields comparable drug survival to interleukin-23 inhibitors after the failure of interleukin-17 inhibitors in patients with psoriasis.

Traveling in Europe: Should Mosquito Risks Be on Your Radar?

Travel medicine specialists say that mosquito protection deserves the same attention as sunscreen because vector-borne infections become more common in Europe.

To Heal Stubborn Wounds, Scientists Look to Nanomaterials

Slow-healing lesions — common in diabetics and burn victims — can lead to lingering infections that resist antibiotic treatment. A new approach using light-activated therapies may offer a solution.

US FDA Reverses Course on Regenxbio's Rare-disease Gene Therapy, Backs Accelerated Approval Bid

Regenxbio said on Monday the U.S. FDA has indicated that existing data for its rare-disease gene therapy could support ⁠an accelerated approval application, reversing course...

Geographic and Income Data Missing From Cancer Trial Reports

Researchers conducted a systematic review of 441 US-based randomized cancer treatment trials to see what patient characteristics were reported.

Can Printed ‘Skin’ Help to Heal Burns Without Scars?

Inks created with a patient’s own cells may one day help the body regrow tissues.

Todays Updates

Time to Rethink Maintenance Pemetrexed in NSCLC?

For patients with advanced non-small cell lung cancer (NSCLC), adding pemetrexed to maintenance pembrolizumab may only increase toxicity, not survival.

Todays Updates

Time to Rethink Maintenance Pemetrexed in NSCLC?

For patients with advanced non-small cell lung cancer (NSCLC), adding pemetrexed to maintenance pembrolizumab may only increase toxicity, not survival.

Latest News

A retrospective study finds that bimekizumab yields comparable drug survival to interleukin-23 inhibitors after the failure of interleukin-17 inhibitors in patients with psoriasis.

Travel medicine specialists say that mosquito protection deserves the same attention as sunscreen because vector-borne infections become more common in Europe.

Slow-healing lesions — common in diabetics and burn victims — can lead to lingering infections that resist antibiotic treatment. A new approach using light-activated therapies may offer a solution.

Regenxbio said on Monday the U.S. FDA has indicated that existing data for its rare-disease gene therapy could support ⁠an accelerated approval application, reversing course...

Researchers conducted a systematic review of 441 US-based randomized cancer treatment trials to see what patient characteristics were reported.

Inks created with a patient’s own cells may one day help the body regrow tissues.

News All Time

Social Media Sunscreen Recipes Raise Safety Concerns

Homemade sunscreen recipes are gaining attention, but laboratory studies suggest they may reduce ultraviolet damage unevenly and fail against key sunburn markers.

Cutaneous Lupus Flares Peak During Late Perimenopause

Cutaneous lupus flares increase during late perimenopause and remain elevated after menopause, study finds.

Somatic Cancer Symptoms May Be Overattributed to Depression

Experts offer advice for treating symptoms of ovarian, breast, and other cancers that are not driven by depression and explain why it’s essential to discern the difference.

UKHSA: New Pandemic More Than 25% Likely Within 5 Years

Influenza and novel coronavirus top a new UKHSA threat register covering 22 risks, from dengue to drug-resistant infections.

Most OTC Vaginal Moisturizers Contain Contact Allergens

Over-the-counter vaginal and vulvar moisturizers often contain allergens, with inaccurate marketing claims, a study shows.

Takeda's AI-crafted Psoriasis Pill Tops Bristol Myers' Sotyktu in Head-to-head Trial

Japan's Takeda Pharmaceutical said on Thursday its experimental once-daily psoriasis pill, developed with the help of AI, outperformed Bristol ⁠Myers Squibb's approved drug...

Drop Flare Fears to Fix Rheumatic Vaccination Gaps

Vaccination remains the best measure to protect immunosuppressed patients, but new evidence suggests a rethink of scheduling.

Secondary Syphilis Sign Shows Reliable Histologic Pattern

Condyloma lata in secondary syphilis shows consistent histopathologic findings that may help prevent misdiagnosis.

Can Age-Old Chinese Therapy Reduce Insulin Needs in T2D?

Acupuncture may reduce insulin requirements to a greater extent than a sham treatment in adults with type 2 diabetes and overweight receiving insulin therapy, a trial suggests.

Golimumab Shows Benefit in Refractory HS

More than half of patients with treatment-refractory hidradenitis suppurativa achieve meaningful disease improvement with golimumab therapy in a study.

Psoriasis in Pregnancy: Study Supports Safety of Biologics

In pregnant women with psoriasis, biologic therapy is not linked to increased risk for adverse maternal or neonatal outcomes compared with unexposed patients, study finds.

How Can Canada Improve Access to Dermatologic Care?

The Canadian Dermatology Association proposes increasing residency spots, expanding technology, and integrating international graduates into the workforce.

Choosing a Journal: What Matters More Than Impact Factor?

Researchers weigh peer review, indexing, transparency, and audience reach alongside impact factor when deciding where to submit scientific work.

Bimekizumab Gives Lasting Symptom Relief in PsA

In patients with psoriatic arthritis, long-term bimekizumab treatment shows sustained improvement in symptoms and disease impact, according to an analysis of data from two phase 3 trials.

Dr. Bolu Ogunyemi Becomes New CMA President

Bolu Ogunyemi, MD, dermatologist from St. John’s, Newfoundland and Labrador, has become the Canadian Medical Association’s first Black president and is among its youngest.